25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

0PT (Prothena) Stock Analysis
Buy, Hold or Sell?

Let's analyze Prothena together

I guess you are interested in Prothena Corporation plc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Prothena’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Prothena’s Price Targets

I'm going to help you getting a better view of Prothena Corporation plc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Prothena Corporation plc

I send you an email if I find something interesting about Prothena Corporation plc.

1. Quick Overview

1.1. Quick analysis of Prothena (30 sec.)










1.2. What can you expect buying and holding a share of Prothena? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€6.95
Expected worth in 1 year
€5.93
How sure are you?
26.5%

+ What do you gain per year?

Total Gains per Share
€-1.03
Return On Investment
-19.6%

For what price can you sell your share?

Current Price per Share
€5.25
Expected price per share
€5.15 - €8.4
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Prothena (5 min.)




Live pricePrice per Share (EOD)
€5.25
Intrinsic Value Per Share
€-28.25 - €-33.08
Total Value Per Share
€-21.29 - €-26.12

2.2. Growth of Prothena (5 min.)




Is Prothena growing?

Current yearPrevious yearGrowGrow %
How rich?$437.6m$565.6m-$55.4m-10.9%

How much money is Prothena making?

Current yearPrevious yearGrowGrow %
Making money-$27.5m-$43.1m$15.5m56.4%
Net Profit Margin-2,722.6%-41,790.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Prothena (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#138 / 872

Most Revenue
#181 / 872

Most Profit
#683 / 872

Most Efficient
#772 / 872
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Prothena?

Welcome investor! Prothena's management wants to use your money to grow the business. In return you get a share of Prothena.

First you should know what it really means to hold a share of Prothena. And how you can make/lose money.

Speculation

The Price per Share of Prothena is €5.25. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Prothena.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Prothena, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €6.95. Based on the TTM, the Book Value Change Per Share is €-0.26 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.42 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Prothena.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 β‚¬% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share
Usd Eps-1.12-21.3%-0.51-9.8%-0.80-15.3%-0.65-12.3%-0.44-8.4%-0.51-9.7%
Usd Book Value Change Per Share-0.91-17.4%-0.30-5.7%-0.49-9.3%0.000.0%0.173.2%0.244.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.91-17.4%-0.30-5.7%-0.49-9.3%0.000.0%0.173.2%0.244.6%
Usd Price Per Share13.33-18.24-48.23-40.49-37.19-33.72-
Price to Earnings Ratio-2.98--1.78-0.46-7.28-3.15--3.20-
Price-to-Total Gains Ratio-14.57--10.48--33.56--158.20--103.03--59.29-
Price to Book Ratio1.64-1.91-4.52-4.14-4.49-4.26-
Price-to-Total Gains Ratio-14.57--10.48--33.56--158.20--103.03--59.29-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.1383
Number of shares162
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.300.17
Usd Total Gains Per Share-0.300.17
Gains per Quarter (162 shares)-48.7027.48
Gains per Year (162 shares)-194.78109.94
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-195-2050110100
20-390-4000220210
30-584-5950330320
40-779-7900440430
50-974-9850550540
60-1169-11800660650
70-1363-13750770760
80-1558-15700880870
90-1753-17650989980
100-1948-1960010991090

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%3.09.00.025.0%5.015.00.025.0%5.029.00.014.7%5.029.00.014.7%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%6.014.00.030.0%9.025.00.026.5%9.025.00.026.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.034.00.0%0.00.034.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%6.014.00.030.0%9.025.00.026.5%9.025.00.026.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Prothena Corporation plc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.783-0.257-67%-0.417-47%-0.002-100%0.145-639%0.205-483%
Book Value Per Share--6.9558.107-14%8.988-23%8.402-17%7.064-2%6.521+7%
Current Ratio--9.00110.767-16%11.679-23%11.818-24%13.141-32%14.589-38%
Debt To Asset Ratio--0.1160.107+9%0.189-38%0.173-33%0.237-51%0.257-55%
Debt To Equity Ratio--0.1320.120+10%0.232-43%0.214-38%0.337-61%0.371-64%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--564314623.200787874724.150-28%2108217883.125-73%1769521330.292-68%1605500347.435-65%1440052290.032-61%
Eps---0.956-0.438-54%-0.685-28%-0.553-42%-0.377-61%-0.436-54%
Ev To Sales Ratio--58.326107.690-46%2107.117-97%840.937-93%707.090-92%996.390-94%
Free Cash Flow Per Share---0.849-0.519-39%-0.645-24%-0.546-36%-0.330-61%-0.332-61%
Free Cash Flow To Equity Per Share---0.849-0.516-39%-0.555-35%-0.166-80%0.115-839%0.092-1022%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---33.075----------
Intrinsic Value_10Y_min---28.247----------
Intrinsic Value_1Y_max---2.351----------
Intrinsic Value_1Y_min---2.308----------
Intrinsic Value_3Y_max---7.798----------
Intrinsic Value_3Y_min---7.429----------
Intrinsic Value_5Y_max---14.130----------
Intrinsic Value_5Y_min---13.052----------
Market Cap282591750.000-117%613627800.000839701200.000-27%2220363750.000-72%1864253289.167-67%1711994648.500-64%1552434005.882-60%
Net Profit Margin---21.285-27.226+28%-417.909+1863%-155.302+630%-128.331+503%-136.241+540%
Operating Margin----0%-4.1370%-6.8880%-37.6030%-81.0600%
Operating Ratio--24.19031.472-23%474.863-95%176.785-86%140.387-83%161.300-85%
Pb Ratio0.755-117%1.6391.907-14%4.523-64%4.138-60%4.490-63%4.260-62%
Pe Ratio-1.372+54%-2.980-1.778-40%0.462-745%7.280-141%3.153-195%-3.198+7%
Price Per Share5.250-117%11.40015.600-27%41.250-72%34.634-67%31.806-64%28.841-60%
Price To Free Cash Flow Ratio-1.547+54%-3.3581.169-387%10.614-132%-15.006+347%-11.346+238%-6.862+104%
Price To Total Gains Ratio-6.709+54%-14.569-10.482-28%-33.558+130%-158.203+986%-103.026+607%-59.286+307%
Quick Ratio----0%0.049-100%0.022-100%0.013-100%0.114-100%
Return On Assets---0.122-0.056-54%-0.065-47%-0.058-52%-0.046-62%-0.054-56%
Return On Equity---0.138-0.063-54%-0.081-41%-0.071-48%-0.064-54%-0.075-46%
Total Gains Per Share---0.783-0.257-67%-0.417-47%-0.002-100%0.145-639%0.205-483%
Usd Book Value--437687335.517510229801.308-14%565676980.587-23%528754945.118-17%444562850.749-2%410401260.563+7%
Usd Book Value Change Per Share---0.915-0.301-67%-0.488-47%-0.002-100%0.170-639%0.239-483%
Usd Book Value Per Share--8.1319.479-14%10.509-23%9.823-17%8.259-2%7.624+7%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--659796657.445921183127.476-28%2464928348.950-73%2068924339.377-68%1877151006.221-65%1683709137.506-61%
Usd Eps---1.118-0.512-54%-0.801-28%-0.647-42%-0.441-61%-0.510-54%
Usd Free Cash Flow---53405895.068-32650297.210-39%-40591680.305-24%-34360325.869-36%-20754997.848-61%-12890863.106-76%
Usd Free Cash Flow Per Share---0.992-0.607-39%-0.754-24%-0.638-36%-0.386-61%-0.388-61%
Usd Free Cash Flow To Equity Per Share---0.993-0.603-39%-0.649-35%-0.194-80%0.134-839%0.108-1022%
Usd Market Cap330406274.100-117%717453623.760981778643.040-27%2596049296.500-72%2179684945.694-67%2001664143.026-64%1815105839.678-60%
Usd Price Per Share6.138-117%13.32918.240-27%48.230-72%40.494-67%37.187-64%33.721-60%
Usd Profit---60196008.868-27566962.015-54%-43101472.369-28%-34183239.568-43%-23354491.415-61%-27239074.166-55%
Usd Revenue--2828047.39734484327.948-92%22313123.962-87%23509310.676-88%24227856.052-88%15122282.857-81%
Usd Total Gains Per Share---0.915-0.301-67%-0.488-47%-0.002-100%0.170-639%0.239-483%
 EOD+3 -5MRQTTM+6 -28YOY+9 -263Y+8 -275Y+8 -2710Y+10 -25

3.3 Fundamental Score

Let's check the fundamental score of Prothena Corporation plc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.372
Price to Book Ratio (EOD)Between0-10.755
Net Profit Margin (MRQ)Greater than0-21.285
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than19.001
Debt to Asset Ratio (MRQ)Less than10.116
Debt to Equity Ratio (MRQ)Less than10.132
Return on Equity (MRQ)Greater than0.15-0.138
Return on Assets (MRQ)Greater than0.05-0.122
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Prothena Corporation plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.099
Ma 20Greater thanMa 505.115
Ma 50Greater thanMa 1005.164
Ma 100Greater thanMa 2008.194
OpenGreater thanClose5.450
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Prothena Corporation plc

Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States. Its product pipeline include Prasinezumab, an investigational humanized monoclonal antibody which is in phase 2b clinical trial, as well as phase 1 and 2 clinical trials for the treatment of parkinson's disease and other synucleinopathies. The company also develops Coramitug, an investigational antibody, which is in phase 2 clinical trial for potential treatment of transthyretin amyloidosis; BMS-986446, an investigational antibody, which is in phase 2 clinical trial to treat Alzheimer's disease; PRX012, an investigational antibody, which is in phase 1 clinical trial to treat Alzheimer's disease; PRX123, a Dual Aß-Tau Vaccine, which is in preclinical trial for treating Alzheimer's disease; and PRX019, an investigational antibody, which is in phase 1 clinical trial for the potential treatment of neurodegenerative diseases. It has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target a-synuclein, including prasinezumab; and master collaboration agreement with Bristol Myers Squibb to develop and commercialize antibodies targeting tau, TDP-43. Prothena Corporation plc was incorporated in 2012 and is based in Dublin, Ireland.

Fundamental data was last updated by Penke on 2025-07-05 05:18:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Prothena earns for each €1 of revenue.

  • Above 10% is considered healthy but always compareΒ Prothena to theΒ Biotechnology industry mean.
  • A Net Profit Margin of -2,128.5%Β means thatΒ €-21.29 for each €1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Prothena Corporation plc:

  • The MRQ is -2,128.5%. The company is making a huge loss. -2
  • The TTM is -2,722.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-2,128.5%TTM-2,722.6%+594.1%
TTM-2,722.6%YOY-41,790.9%+39,068.4%
TTM-2,722.6%5Y-12,833.1%+10,110.5%
5Y-12,833.1%10Y-13,624.1%+791.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,128.5%-91.7%-2,036.8%
TTM-2,722.6%-140.3%-2,582.3%
YOY-41,790.9%-196.4%-41,594.5%
3Y-15,530.2%-247.9%-15,282.3%
5Y-12,833.1%-343.3%-12,489.8%
10Y-13,624.1%-488.1%-13,136.0%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Prothena is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Prothena to theΒ Biotechnology industry mean.
  • -12.2% Return on Assets means thatΒ Prothena generatedΒ €-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Prothena Corporation plc:

  • The MRQ is -12.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.2%TTM-5.6%-6.6%
TTM-5.6%YOY-6.5%+0.9%
TTM-5.6%5Y-4.6%-1.0%
5Y-4.6%10Y-5.4%+0.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.2%-11.5%-0.7%
TTM-5.6%-11.5%+5.9%
YOY-6.5%-11.4%+4.9%
3Y-5.8%-11.7%+5.9%
5Y-4.6%-11.9%+7.3%
10Y-5.4%-13.7%+8.3%
4.3.1.3. Return on Equity

Shows how efficient Prothena is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Prothena to theΒ Biotechnology industry mean.
  • -13.8% Return on Equity means Prothena generated €-0.14Β for eachΒ €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Prothena Corporation plc:

  • The MRQ is -13.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -6.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.8%TTM-6.3%-7.5%
TTM-6.3%YOY-8.1%+1.8%
TTM-6.3%5Y-6.4%+0.1%
5Y-6.4%10Y-7.5%+1.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.8%-13.6%-0.2%
TTM-6.3%-14.8%+8.5%
YOY-8.1%-14.4%+6.3%
3Y-7.1%-16.8%+9.7%
5Y-6.4%-17.5%+11.1%
10Y-7.5%-19.5%+12.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Prothena Corporation plc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Prothena is operatingΒ .

  • Measures how much profit Prothena makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Prothena to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated €0.00 Β for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Prothena Corporation plc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-413.7%+413.7%
TTM-5Y-3,760.3%+3,760.3%
5Y-3,760.3%10Y-8,106.0%+4,345.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--221.8%+221.8%
TTM--250.7%+250.7%
YOY-413.7%-208.5%-205.2%
3Y-688.8%-220.2%-468.6%
5Y-3,760.3%-342.4%-3,417.9%
10Y-8,106.0%-462.5%-7,643.5%
4.3.2.2. Operating Ratio

Measures how efficient Prothena is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 24.19 means that the operating costs are €24.19 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Prothena Corporation plc:

  • The MRQ is 24.190. The company is inefficient in keeping operating costs low. -1
  • The TTM is 31.472. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ24.190TTM31.472-7.282
TTM31.472YOY474.863-443.391
TTM31.4725Y140.387-108.916
5Y140.38710Y161.300-20.913
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ24.1902.097+22.093
TTM31.4722.684+28.788
YOY474.8633.076+471.787
3Y176.7853.524+173.261
5Y140.3874.724+135.663
10Y161.3006.445+154.855
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Prothena Corporation plc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Prothena is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 9.00Β means the company has €9.00 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Prothena Corporation plc:

  • The MRQ is 9.001. The company is very able to pay all its short-term debts. +2
  • The TTM is 10.767. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.001TTM10.767-1.766
TTM10.767YOY11.679-0.912
TTM10.7675Y13.141-2.374
5Y13.14110Y14.589-1.449
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.0013.638+5.363
TTM10.7673.846+6.921
YOY11.6794.140+7.539
3Y11.8184.688+7.130
5Y13.1415.722+7.419
10Y14.5896.144+8.445
4.4.3.2. Quick Ratio

Measures if Prothena is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Prothena to theΒ Biotechnology industry mean.
  • A Quick Ratio of 0.00Β means the company can pay off €0.00 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Prothena Corporation plc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.049-0.049
TTM-5Y0.013-0.013
5Y0.01310Y0.114-0.101
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.826-2.826
TTM-3.116-3.116
YOY0.0493.786-3.737
3Y0.0224.311-4.289
5Y0.0135.702-5.689
10Y0.1146.335-6.221
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Prothena Corporation plc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of ProthenaΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Prothena to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.12Β means that Prothena assets areΒ financed with 11.6% credit (debt) and the remaining percentage (100% - 11.6%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Prothena Corporation plc:

  • The MRQ is 0.116. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.107. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.116TTM0.107+0.010
TTM0.107YOY0.189-0.082
TTM0.1075Y0.237-0.130
5Y0.23710Y0.257-0.020
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1160.327-0.211
TTM0.1070.349-0.242
YOY0.1890.332-0.143
3Y0.1730.340-0.167
5Y0.2370.346-0.109
10Y0.2570.378-0.121
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Prothena is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Prothena to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 13.2% means that company has €0.13 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Prothena Corporation plc:

  • The MRQ is 0.132. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.120. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.132TTM0.120+0.012
TTM0.120YOY0.232-0.113
TTM0.1205Y0.337-0.218
5Y0.33710Y0.371-0.033
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1320.383-0.251
TTM0.1200.438-0.318
YOY0.2320.414-0.182
3Y0.2140.450-0.236
5Y0.3370.457-0.120
10Y0.3710.512-0.141
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every €1 in earnings Prothena generates.

  • Above 15 is considered overpriced butΒ always compareΒ Prothena to theΒ Biotechnology industry mean.
  • A PE ratio of -2.98 means the investor is paying €-2.98Β for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Prothena Corporation plc:

  • The EOD is -1.372. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.980. Based on the earnings, the company is expensive. -2
  • The TTM is -1.778. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.372MRQ-2.980+1.607
MRQ-2.980TTM-1.778-1.202
TTM-1.778YOY0.462-2.240
TTM-1.7785Y3.153-4.931
5Y3.15310Y-3.198+6.350
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.372-2.399+1.027
MRQ-2.980-2.092-0.888
TTM-1.778-2.625+0.847
YOY0.462-3.784+4.246
3Y7.280-3.762+11.042
5Y3.153-6.363+9.516
10Y-3.198-7.055+3.857
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Prothena Corporation plc:

  • The EOD is -1.547. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.358. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 1.169. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-1.547MRQ-3.358+1.812
MRQ-3.358TTM1.169-4.527
TTM1.169YOY10.614-9.445
TTM1.1695Y-11.346+12.515
5Y-11.34610Y-6.862-4.484
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.547-3.299+1.752
MRQ-3.358-2.742-0.616
TTM1.169-3.801+4.970
YOY10.614-4.402+15.016
3Y-15.006-5.140-9.866
5Y-11.346-8.483-2.863
10Y-6.862-9.296+2.434
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Prothena is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 1.64 means the investor is paying €1.64Β for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Prothena Corporation plc:

  • The EOD is 0.755. Based on the equity, the company is cheap. +2
  • The MRQ is 1.639. Based on the equity, the company is underpriced. +1
  • The TTM is 1.907. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.755MRQ1.639-0.884
MRQ1.639TTM1.907-0.268
TTM1.907YOY4.523-2.616
TTM1.9075Y4.490-2.584
5Y4.49010Y4.260+0.231
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.7552.113-1.358
MRQ1.6391.856-0.217
TTM1.9072.125-0.218
YOY4.5232.454+2.069
3Y4.1382.492+1.646
5Y4.4903.668+0.822
10Y4.2604.364-0.104
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets495,336
Total Liabilities57,656
Total Stockholder Equity437,680
 As reported
Total Liabilities 57,656
Total Stockholder Equity+ 437,680
Total Assets = 495,336

Assets

Total Assets495,336
Total Current Assets436,173
Long-term Assets59,163
Total Current Assets
Cash And Cash Equivalents 417,935
Other Current Assets 1,016
Total Current Assets  (as reported)436,173
Total Current Assets  (calculated)418,951
+/- 17,222
Long-term Assets
Property Plant Equipment 12,898
Long-term Assets Other 1,354
Long-term Assets  (as reported)59,163
Long-term Assets  (calculated)14,252
+/- 44,911

Liabilities & Shareholders' Equity

Total Current Liabilities48,459
Long-term Liabilities9,197
Total Stockholder Equity437,680
Total Current Liabilities
Accounts payable 16,027
Other Current Liabilities 1,586
Total Current Liabilities  (as reported)48,459
Total Current Liabilities  (calculated)17,613
+/- 30,846
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt10,203
Long-term Liabilities  (as reported)9,197
Long-term Liabilities  (calculated)10,203
+/- 1,006
Total Stockholder Equity
Total Stockholder Equity (as reported)437,680
Total Stockholder Equity (calculated)0
+/- 437,680
Other
Capital Stock538
Common Stock Shares Outstanding 53,827
Net Invested Capital 437,680
Net Working Capital 387,714
Property Plant and Equipment Gross 21,297



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
459,976
581,950
579,000
537,680
496,329
606,647
563,300
524,626
498,796
459,534
462,072
450,894
419,268
399,421
378,933
355,784
332,975
379,719
436,378
632,704
609,366
581,412
549,589
554,440
758,035
741,586
720,649
746,920
696,382
623,194
645,565
595,254
547,108
495,336
495,336547,108595,254645,565623,194696,382746,920720,649741,586758,035554,440549,589581,412609,366632,704436,378379,719332,975355,784378,933399,421419,268450,894462,072459,534498,796524,626563,300606,647496,329537,680579,000581,950459,976
   > Total Current Assets 
391,362
514,204
511,720
469,064
426,327
537,153
494,037
456,908
431,390
415,193
418,708
409,202
378,375
359,691
341,123
320,485
299,284
352,301
409,468
607,530
584,809
555,620
521,294
524,562
719,098
700,343
677,103
690,604
639,282
565,868
585,978
534,984
485,412
436,173
436,173485,412534,984585,978565,868639,282690,604677,103700,343719,098524,562521,294555,620584,809607,530409,468352,301299,284320,485341,123359,691378,375409,202418,708415,193431,390456,908494,037537,153426,327469,064511,720514,204391,362
       Cash And Cash Equivalents 
386,923
506,550
471,729
456,061
417,620
429,039
486,212
451,512
427,659
410,106
398,144
390,304
375,723
352,685
333,942
314,525
295,380
342,993
399,831
600,098
579,094
542,994
508,795
495,628
710,406
686,184
659,111
670,897
618,830
546,512
564,124
519,262
471,388
417,935
417,935471,388519,262564,124546,512618,830670,897659,111686,184710,406495,628508,795542,994579,094600,098399,831342,993295,380314,525333,942352,685375,723390,304398,144410,106427,659451,512486,212429,039417,620456,061471,729506,550386,923
       Net Receivables 
178
271
30,240
220
240
100,012
8
0
2
7
0
42
68
174
56
22
15
1
3
79
0
0
0
3,267
62
0
524
5,159
5,159
0
0
0
0
0
000005,1595,1595240623,2670007931152256174684207208100,01224022030,240271178
       Other Current Assets 
4,261
7,383
9,751
12,783
8,707
8,102
0
0
3,729
1,352
17,102
18,856
0
0
0
1,352
1,352
1,352
1,352
0
5,715
12,626
12,499
17,214
1,708
3,270
1,352
3,051
2,140
1,037
1,008
1,065
1,165
1,016
1,0161,1651,0651,0081,0372,1403,0511,3523,2701,70817,21412,49912,6265,71501,3521,3521,3521,35200018,85617,1021,3523,729008,1028,70712,7839,7517,3834,261
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
44,341
43,364
41,692
40,893
39,730
37,810
35,299
33,691
27,418
26,910
25,174
24,557
25,792
28,295
29,878
38,937
41,243
43,546
56,316
57,100
57,326
59,587
60,270
61,696
59,163
59,16361,69660,27059,58757,32657,10056,31643,54641,24338,93729,87828,29525,79224,55725,17426,91027,41833,69135,29937,81039,73040,89341,69243,36444,341000000000
       Property Plant Equipment 
56,452
56,084
55,843
55,384
54,990
54,278
53,398
52,951
52,835
31,866
30,245
28,852
27,148
25,460
23,785
22,096
20,362
18,706
17,076
15,511
14,135
12,529
11,201
9,805
8,008
6,643
5,477
15,062
15,998
16,182
15,552
14,654
13,789
12,898
12,89813,78914,65415,55216,18215,99815,0625,4776,6438,0089,80511,20112,52914,13515,51117,07618,70620,36222,09623,78525,46027,14828,85230,24531,86652,83552,95153,39854,27854,99055,38455,84356,08456,452
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
3,572
3,627
3,381
3,789
3,819
3,008
1,679
13,329
1,690
3,403
3,160
10,422
3,671
5,136
20,073
30,929
13,167
12,127
11,338
7,209
4,469
4,552
4,614
4,668
1,354
1,3544,6684,6144,5524,4697,20911,33812,12713,16730,92920,0735,1363,67110,4223,1603,4031,69013,3291,6793,0083,8193,7893,3813,6273,572000000000
> Total Liabilities 
94,573
85,702
92,024
91,426
89,140
197,142
207,294
184,976
175,798
147,404
159,265
161,719
146,347
144,382
144,489
146,270
148,969
145,135
148,171
142,233
143,324
142,525
142,290
149,792
135,993
134,177
138,970
129,693
135,017
120,795
63,648
60,892
60,182
57,656
57,65660,18260,89263,648120,795135,017129,693138,970134,177135,993149,792142,290142,525143,324142,233148,171145,135148,969146,270144,489144,382146,347161,719159,265147,404175,798184,976207,294197,14289,14091,42692,02485,70294,573
   > Total Current Liabilities 
41,075
33,680
39,599
39,258
37,371
35,555
46,132
23,627
14,926
14,906
28,016
31,763
17,714
17,086
18,544
21,722
25,848
23,456
52,899
29,201
33,452
36,496
40,107
50,598
50,147
48,884
71,565
53,370
56,891
43,266
46,744
46,422
48,501
48,459
48,45948,50146,42246,74443,26656,89153,37071,56548,88450,14750,59840,10736,49633,45229,20152,89923,45625,84821,72218,54417,08617,71431,76328,01614,90614,92623,62746,13235,55537,37139,25839,59933,68041,075
       Short-term Debt 
51,320
51,735
52,148
52,274
52,248
52,202
52,165
0
0
4,810
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000004,8100052,16552,20252,24852,27452,14851,73551,320
       Short Long Term Debt 
51,320
51,735
52,148
52,274
52,248
52,202
52,165
0
0
4,810
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000004,8100052,16552,20252,24852,27452,14851,73551,320
       Accounts payable 
32,520
28,349
12,545
11,062
13,633
11,590
10,052
4,485
1,470
2,103
1,525
2,418
1,242
3,297
2,124
2,810
4,117
4,212
5,908
3,483
3,691
9,316
7,551
9,788
9,270
12,523
13,851
19,458
25,391
14,420
9,286
10,330
7,770
16,027
16,0277,77010,3309,28614,42025,39119,45813,85112,5239,2709,7887,5519,3163,6913,4835,9084,2124,1172,8102,1243,2971,2422,4181,5252,1031,4704,48510,05211,59013,63311,06212,54528,34932,520
       Other Current Liabilities 
8,555
5,331
1,670
1,449
1,716
2,043
19,891
6,768
837
783
673
681
327
558
894
873
552
246
25,492
7,633
8,062
10,044
10,675
10,379
11,945
1,825
49,190
3,106
2,417
1,964
1,120
1,439
1,375
1,586
1,5861,3751,4391,1201,9642,4173,10649,1901,82511,94510,37910,67510,0448,0627,63325,4922465528738945583276816737838376,76819,8912,0431,7161,4491,6705,3318,555
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
132,498
131,249
129,956
128,633
127,296
125,945
124,548
123,121
121,679
95,272
113,032
109,872
106,029
102,183
99,194
85,846
85,293
67,405
76,323
78,126
77,529
16,904
14,470
11,681
9,197
9,19711,68114,47016,90477,52978,12676,32367,40585,29385,84699,194102,183106,029109,872113,03295,272121,679123,121124,548125,945127,296128,633129,956131,249132,498000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
26,513
25,358
24,163
22,939
21,703
20,454
19,161
17,838
16,501
15,149
13,753
12,326
10,884
9,577
8,034
6,473
4,885
3,448
10,735
11,835
12,496
12,117
11,494
10,843
10,203
10,20310,84311,49412,11712,49611,83510,7353,4484,8856,4738,0349,57710,88412,32613,75315,14916,50117,83819,16120,45421,70322,93924,16325,35826,513000000000
       Other Liabilities 
98
287
277
266
254
110,485
110,471
111,011
110,971
110,795
110,795
110,795
110,795
110,795
110,795
110,795
110,795
110,795
85,846
105,110
103,486
101,195
98,905
97,545
85,846
0
67,405
0
0
0
0
0
0
0
000000067,405085,84697,54598,905101,195103,486105,11085,846110,795110,795110,795110,795110,795110,795110,795110,795110,795110,971111,011110,471110,48525426627728798
> Total Stockholder Equity
365,403
496,248
486,976
446,254
407,189
409,505
356,006
339,650
322,998
312,130
302,807
289,175
272,921
255,039
234,444
209,514
184,006
234,584
288,207
490,471
466,042
438,887
407,299
404,648
622,042
607,409
581,679
617,227
561,365
502,399
581,917
534,362
486,926
437,680
437,680486,926534,362581,917502,399561,365617,227581,679607,409622,042404,648407,299438,887466,042490,471288,207234,584184,006209,514234,444255,039272,921289,175302,807312,130322,998339,650356,006409,505407,189446,254486,976496,248365,403
   Common Stock
348
380
382
384
385
398
398
398
399
399
399
399
399
399
399
399
399
442
449
465
466
467
468
479
521
0
581,679
0
0
0
0
0
0
0
0000000581,6790521479468467466465449442399399399399399399399399399398398398385384382380348
   Retained Earnings Total Equity0000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000
   Other Stockholders Equity 0000000000000000000000000000000000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue135,157
Cost of Revenue--
Gross Profit-135,157
 
Operating Income (+$)
Gross Profit-
Operating Expense-289,718
Operating Income-154,561-289,718
 
Operating Expense (+$)
Research Development222,519
Selling General Administrative67,199
Selling And Marketing Expenses-
Operating Expense289,718289,718
 
Net Interest Income (+$)
Interest Income25,816
Interest Expense--
Other Finance Cost-0
Net Interest Income25,816
 
Pretax Income (+$)
Operating Income-154,561
Net Interest Income25,816
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-128,930-154,376
EBIT - interestExpense = 0
-122,310
-122,310
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--128,930
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-128,930
Tax Provision--6,620
Net Income From Continuing Ops-122,310-122,310
Net Income-122,310
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-185-25,816
 

Technical Analysis of Prothena
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Prothena. The general trend of Prothena is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Prothena's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Prothena Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Prothena Corporation plc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 7.9 < 7.9 < 8.4.

The bearish price targets are: 5.15 > 5.15 > 5.15.

Know someone who trades $0PT? Share this with them.πŸ‘‡

Prothena Corporation plc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Prothena Corporation plc. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Prothena Corporation plc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Prothena Corporation plc. The current macd is 0.05135.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Prothena price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Prothena. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Prothena price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Prothena Corporation plc Daily Moving Average Convergence/Divergence (MACD) ChartProthena Corporation plc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Prothena Corporation plc. The current adx is 16.70.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Prothena shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Prothena Corporation plc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Prothena Corporation plc. The current sar is 4.87897577.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Prothena Corporation plc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Prothena Corporation plc. The current rsi is 52.10. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Prothena Corporation plc Daily Relative Strength Index (RSI) ChartProthena Corporation plc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Prothena Corporation plc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Prothena price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Prothena Corporation plc Daily Stochastic Oscillator ChartProthena Corporation plc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Prothena Corporation plc. The current cci is 84.15.

Prothena Corporation plc Daily Commodity Channel Index (CCI) ChartProthena Corporation plc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Prothena Corporation plc. The current cmo is 10.54.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Prothena Corporation plc Daily Chande Momentum Oscillator (CMO) ChartProthena Corporation plc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Prothena Corporation plc. The current willr is -40.81632653.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Prothena is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Prothena Corporation plc Daily Williams %R ChartProthena Corporation plc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Prothena Corporation plc.

Prothena Corporation plc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Prothena Corporation plc. The current atr is 0.15397163.

Prothena Corporation plc Daily Average True Range (ATR) ChartProthena Corporation plc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Prothena Corporation plc. The current obv is 8,576.

Prothena Corporation plc Daily On-Balance Volume (OBV) ChartProthena Corporation plc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Prothena Corporation plc. The current mfi is 60.07.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Prothena Corporation plc Daily Money Flow Index (MFI) ChartProthena Corporation plc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Prothena Corporation plc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-20 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-24 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-02-25 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-27 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-28 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-03 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-04 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-05 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-10 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-11 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-12 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-14 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-18 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-19 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-25 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-26 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-27 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-31 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-01 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-02 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-07 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-10 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-11 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-14 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-25 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-29 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-30 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-02 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-05 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-06 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-12 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-13 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-05-14 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-15 00:00:00MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-16 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-23 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-26 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-30 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-03 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-05 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-06 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-10 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-13 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-06-16 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-19 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-20 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-23 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-25 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-26 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-27 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-03 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-09 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-10 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-11 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Prothena Corporation plc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Prothena Corporation plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.099
Ma 20Greater thanMa 505.115
Ma 50Greater thanMa 1005.164
Ma 100Greater thanMa 2008.194
OpenGreater thanClose5.450
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Prothena with someone you think should read this too:
  • Are you bullish or bearish on Prothena? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Prothena? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Prothena Corporation plc

I send you an email if I find something interesting about Prothena Corporation plc.


Comments

How you think about this?

Leave a comment

Stay informed about Prothena Corporation plc.

Receive notifications about Prothena Corporation plc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.